8-K
filed May 11, 2023, 7:59 PM ET
ticker MD
CIK 0000893949
other
confidence high
sentiment neutral
materiality 0.15
Pediatrix Medical Group shareholders elect directors, ratify auditor, approve say-on-pay at 2023 Annual Meeting
Pediatrix Medical Group, Inc.
- All 8 director nominees elected; Michael Rucker received lowest support with 68.6M for, 7.3M against.
- Ratified PricewaterhouseCoopers as independent auditor for FY2023 (74.4M for, 4.3M against).
- Advisory vote on 2022 executive compensation passed with 73.6M for, 2.3M against.
- Shareholders indicated preference for annual advisory votes on exec comp (71.9M for one year).
- Board adopted annual frequency for future say-on-pay votes.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Pediatrix Medical Group, Inc. shareholders approved Election of Directors at the 2023-05-11 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-05-11
Exact text from the filing
Proposal 1: All of the nominees for the Company’s Board of Directors were elected to serve until the Company’s 2024 Annual Shareholders’ Meeting or until their respective successors are elected and qualified, by the votes set forth in the table below: Name For Against Abstained Broker Non-Vote Laura A. Linynsky 74,814,862 1,062,561 31,805 2,770,115 Thomas A. McEachin 74,748,365 1,131,638 29,225 2,770,115 Mark S. Ordan 73,978,210 1,904,201 26,817 2,770,115 Michael A. Rucker 68,578,436 7,298,897 31,895 2,770,115 Guy P. Sansone 75,113,470 764,042 31,716 2,770,115 John M. Starcher, Jr. 74,815,365 1,061,736 32,127 2,770,115 James D. Swift, M.D. 75,468,494 411,167 29,567 2,770,115 Shirley A. Weis 74,298,008 1,579,336 31,884 2,770,115
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Pediatrix Medical Group, Inc. shareholders approved Advisory vote on frequency of future advisory votes on executive compensation at the 2023-05-11 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-05-11
Exact text from the filing
Proposal 4: The Company's shareholders indicated, on a non-binding, advisory basis, a preference to hold future advisory votes on executive compensation every year, by the votes set forth in the table below: One Year Two Year Three Year Abstained Broker Non-Vote 71,890,793 60,488 3,922,750 35,197 2,770,115
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Pediatrix Medical Group, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2023 at the 2023-05-11 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-05-11
Exact text from the filing
Proposal 2: The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2023 fiscal year was ratified by the Company’s shareholders, by the votes set forth in the table below: For Against Abstained Broker Non-Vote 74,381,705 4,272,655 24,983 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Pediatrix Medical Group, Inc. shareholders approved Advisory vote on executive compensation for 2022 fiscal year at the 2023-05-11 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-05-11
Exact text from the filing
Proposal 3: The Company’s shareholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers for the 2022 fiscal year, by the votes set forth in the table below: For Against Abstained Broker Non-Vote 73,569,327 2,311,935 27,966 2,770,115
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.